Yu Saida

482 total citations
24 papers, 282 citations indexed

About

Yu Saida is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yu Saida has authored 24 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Yu Saida's work include Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Yu Saida is often cited by papers focused on Lung Cancer Research Studies (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). Yu Saida collaborates with scholars based in Japan, United States and Denmark. Yu Saida's co-authors include Shun Kishimoto, Jeffrey Brender, Satoshi Watanabe, Murali C. Krishna, Kazutoshi Yamamoto, Satoru Miura, Koichiro Nozaki, James B. Mitchell, Gadisetti V.R. Chandramouli and Toshiaki Kikuchi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Yu Saida

20 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Saida Japan 12 134 79 68 53 45 24 282
Miriam Braeuer Germany 7 158 1.2× 67 0.8× 49 0.7× 80 1.5× 127 2.8× 8 339
Gaurav Kumar Israel 11 124 0.9× 112 1.4× 67 1.0× 74 1.4× 45 1.0× 14 447
Jason V. Evans United States 7 86 0.6× 143 1.8× 36 0.5× 53 1.0× 26 0.6× 12 295
Yung-Hua Wang United States 9 116 0.9× 90 1.1× 46 0.7× 45 0.8× 102 2.3× 18 282
Hind Nassar Warzecha Germany 6 186 1.4× 74 0.9× 73 1.1× 107 2.0× 58 1.3× 7 347
Justin C. Jagodinsky United States 12 228 1.7× 129 1.6× 146 2.1× 62 1.2× 36 0.8× 19 449
Weihua Lou China 8 125 0.9× 103 1.3× 78 1.1× 52 1.0× 8 0.2× 23 328
Silpa Nuthalapati United States 12 213 1.6× 151 1.9× 37 0.5× 29 0.5× 24 0.5× 28 376
Kian Kani United States 12 177 1.3× 245 3.1× 51 0.8× 60 1.1× 87 1.9× 21 438

Countries citing papers authored by Yu Saida

Since Specialization
Citations

This map shows the geographic impact of Yu Saida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Saida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Saida more than expected).

Fields of papers citing papers by Yu Saida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Saida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Saida. The network helps show where Yu Saida may publish in the future.

Co-authorship network of co-authors of Yu Saida

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Saida. A scholar is included among the top collaborators of Yu Saida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Saida. Yu Saida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Susumu, Koichiro Nozaki, Satoshi Watanabe, et al.. (2025). Risk of lung injury with immune checkpoint inhibitors after talc pleurodesis: A retrospective study. Lung Cancer. 204. 108590–108590.
2.
Watanabe, Satoshi, Masaki Tominaga, Takuya Yagi, et al.. (2024). 18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors. Academic Radiology. 32(2). 1026–1035. 2 indexed citations
3.
5.
Saida, Yu, Satoshi Watanabe, & Toshiaki Kikuchi. (2023). Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects. OncoTargets and Therapy. Volume 16. 657–671. 13 indexed citations
6.
Kishimoto, Shun, Yu Saida, Kazutoshi Yamamoto, et al.. (2023). Evofosfamide and Gemcitabine Act Synergistically in Pancreatic Cancer Xenografts by Dual Action on Tumor Vasculature and Inhibition of Homologous Recombination DNA Repair. Antioxidants and Redox Signaling. 39(7-9). 432–444. 3 indexed citations
7.
Ichikawa, Kosuke, Satoshi Watanabe, Satoru Miura, et al.. (2022). Prognostic significance of procalcitonin in small cell lung cancer. Translational Lung Cancer Research. 11(1). 43–52. 11 indexed citations
8.
Seki, Tomohiro, Yu Saida, Shun Kishimoto, et al.. (2022). PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study. Neoplasia. 30. 100793–100793. 18 indexed citations
9.
Watanabe, Satoshi, Satoshi Shoji, Koichiro Nozaki, et al.. (2022). Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients. Translational Lung Cancer Research. 11(9). 1858–1865. 5 indexed citations
10.
Saida, Yu, Jeffrey Brender, Kazutoshi Yamamoto, et al.. (2021). Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade. Cancer Research. 81(13). 3693–3705. 18 indexed citations
11.
Brender, Jeffrey, et al.. (2021). Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy. Antioxidants and Redox Signaling. 36(1-3). 144–159. 17 indexed citations
12.
Yamamoto, Kazutoshi, Ana Christina L. Opina, Keita Saito, et al.. (2021). Real-Time insight into in vivo redox status utilizing hyperpolarized [1-13C] N-acetyl cysteine. Scientific Reports. 11(1). 12155–12155. 8 indexed citations
13.
Brender, Jeffrey, Shun Kishimoto, Gareth R. Eaton, et al.. (2020). Trehalose as an alternative to glycerol as a glassing agent for in vivo DNP MRI. Magnetic Resonance in Medicine. 85(1). 42–48. 12 indexed citations
14.
Kishimoto, Shun, Jeffrey Brender, Gadisetti V.R. Chandramouli, et al.. (2020). Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy. Antioxidants and Redox Signaling. 35(11). 904–915. 33 indexed citations
15.
Watanabe, Satoshi, Masashi Arita, Miho Takahashi, et al.. (2017). Effect of Lymphodepletion on Donor T Cells and the Role of Recipient Cells Persisting after Cytotoxic Treatments in Cancer Immunotherapies. Critical Reviews in Immunology. 37(1). 59–73. 5 indexed citations
16.
Saida, Yu, et al.. (2015). A Case of Lung Adenocarcinoma with an EGFR-activating Mutation That Transformed to Small-cell Lung Cancer. Haigan. 55(3). 155–160. 1 indexed citations
17.
Shinohara, Hirohiko, et al.. (2015). A Case of Pneumonic-type Adenocarcinoma of the Lung Improved by Pneumonectomy of the Left Lung. Haigan. 55(1). 20–23.
18.
Koshio, Jun, Hiroshi Kagamu, Koichiro Nozaki, et al.. (2013). DEAD/H (Asp–Glu–Ala–Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells. Cancer Immunology Immunotherapy. 62(10). 1619–1628. 24 indexed citations
19.
Saida, Yu, Noriyuki Homma, Hitomi Hama, et al.. (2010). [Case of IgG4-related tubulointerstitial nephritis showing the progression of renal dysfunction after a cure for autoimmune pancreatitis].. PubMed. 52(1). 73–9. 18 indexed citations
20.
Saida, Yu, et al.. (1959). Clinical experiment of variotin.. PubMed. 12. 222–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026